Microsoft Is About to Return an Absurd Amount of Cash to Shareholders
The board just approved a new repurchase program and raised its dividend.
Will Your Social Security Benefit Fall Short of the $3,895 Monthly Maximum?
Most people won’t get anywhere near that amount.
2 Stocks to Buy With Dividends Yielding More Than 4%
These two triple-net-lease REITs offer safe and reliable yields to dividend investors at fair valuations.
4 Companies That Could Be Worth $1 Trillion by 2035
The growth potential in these stocks is too hard to ignore.
What to Like About Veeva Systems’ Q2 Results
This successful cloud-based software provider continues to deliver exceptional growth.
Why Peloton Is a Great Business Before, During, and Even After the Pandemic
It did great in 2020, but it was doing great before the pandemic and its customer satisfaction scores suggest it will keep doing well into the future.
2 Ways to Invest in Life Science Real Estate Through Stocks
Here’s one of the hottest subsectors of commercial real estate.
Here’s My Top Value Stock to Buy Right Now
This mortgage stock’s value and income make a great combination.
Can You Retire a Millionaire on a $60,000 Salary?
Many people aim to retire wealthy. But is that possible when your earnings are only average?
Are You Losing 37% of Your Stock Gains by Making This Common Mistake?
This investment mistake can eat up a huge chunk of your returns.
Why Is Everyone Talking About the Mega Backdoor Roth IRA?
Congress’ new tax proposal makes some big changes to retirement savings.
Should You Be Worried About a Stock Market Crash? Here’s What the Data Suggests
The answer depends on your investing style.
Is Social Security Really Going Broke?
Is the program’s impending financial doom just a rumor, or reality?
Required Reading
This week, the scourge of immersive exhibitions, the popularity of anti-vax deathbed videos, the pregnant man emoji, Chomsky on Afghanistan, Met Gala commentary, and more.
Allergies to mRNA-based COVID-19 vaccines rare, generally mild, study finds
Allergic reactions to the new mRNA-based COVID-19 vaccines are rare, typically mild and treatable, and they should not deter people from becoming vaccinated, according to researchers.
Discovery highlights the complex lifestyles of frontline immune cells
Researchers have made a surprise discovery about how immune ‘sentinel’ cells are maintained, which could have implications for drugs in development for treating cancer.
Brain microstructural damage related to cognitive dysfunction and steroid medication in lupus patients
Researchers attempted to unravel such mechanisms by adopting non-invasive diffusion magnetic resonance imaging (MRI) to study the brains of SLE patients, particularly the white matter, coupled with computerized neuropsychological assessment. White matt…
Now we’re cooking with lasers
Imagine having your own digital personal chef; ready to cook whatever you want, tailoring the shape, texture, and flavor just for you — all at the push of a button. Engineers have been working on doing just that, using lasers for cooking and 3D printi…
Ancient DNA rewrites early Japanese history — modern day populations have tripartite genetic origin
Researchers have extracted Ancient DNA from human bones to re-write early Japanese history by underlining that modern day populations in Japan have a tripartite genetic origin — a finding that refines previously accepted views of a dual genomic ancest…
Lessons from how bats resist COVID could inform new treatments in humans
A new paper explores the idea that studying bats’ responses to SARS-CoV-2 may provide key insights into how and when to best use existing therapies for COVID-19, and to develop new treatments. The paper is a major review of how the virus that has cause…